New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
15:31 EDTSTJ, BLKBlackRock reports 6.37% passive stake in St. Jude Medical
News For STJ;BLK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
07:20 EDTBLKFederal Reserve Bank of Atlanta to hold a conference
Subscribe for More Information
March 26, 2015
18:28 EDTBLKBlackRock, First Reserve to acquire equity stakes in PEMEX pipeline projects
Subscribe for More Information
March 23, 2015
07:43 EDTBLKOcwen issues rebuttal letter to trustees
Subscribe for More Information
06:29 EDTBLKOcwen responds to investor allegations, WSJ says
Subscribe for More Information
March 20, 2015
09:19 EDTBLKBlackRock management to meet with JPMorgan
Meetings to be held in Boston on March 24-25 hosted by JPMorgan.
March 19, 2015
07:42 EDTBLKThe Federal Energy Regulatory Commission (FERC) to hold a meeting
The Commission discusses Duke Energy Carolinas, Duke Energy Progress, Black Hills Power and Westar Energy in an Open Commission Meeting being held at FERC Washington, D.C.'s offices on March 19 at 10 am. Webcast Link
March 18, 2015
10:00 EDTSTJOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:18 EDTBLKWells Fargo to hold a forum
Subscribe for More Information
05:39 EDTSTJSt. Jude Medical downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded St. Jude Medical (STJ) to Market Perform saying competitive pressures will drive 2015 market share losses in the company's cardiac rhythm management business, which represents 50% of total sales. Wells believes the launch of CardioMEMS will not be strong enough to offset the headwinds in CRM unit. The firm thinks Boston Scientific's (BSX) earlier than expected approval for its next generation subcutaneous implantable cardioverter-defibrillator called Emblem will drive share gains against St. Jude and Medtronic (MDT) in the single chamber ICD market. Wells cut its price target range for St. Jude shares to $69-$70 from $73-$74. The medical technology company closed yesterday down $2.01 to $65.45.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use